Crossmark

Etoposide treatment in secondary hemophagocytic syndrome: impact on healthcare-associated infections and survival

Crossref DOI link: https://doi.org/10.1186/s13613-022-01075-9

Published Print: 2022

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Dupont, Thibault https://orcid.org/0000-0002-2401-7873
Darmon, Michael

Mariotte, Eric

Lemiale, Virginie

Fadlallah, Jehane

Mirouse, Adrien

Zafrani, Lara

Azoulay, Elie

Valade, Sandrine
License Information

Text and Data Mining valid from 2022-01-01

Text and Data Mining valid from 2022-01-01

Version of Record valid from 2025-11-19
More Information

This article is maintained by: Elsevier

Article Title: Etoposide treatment in secondary hemophagocytic syndrome: impact on healthcare-associated infections and survival

Journal Title: Annals of Intensive Care

CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s13613-022-01075-9

Content Type: article

Copyright: Copyright © 2022 The Author(s) 2022. Published by Elsevier Masson SAS